Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis

Infection and Immunity

Volumn 71, Issue 9, 2003, Pages 4996-5004

  La Flamme, Anne Camille ^a   Ruddenklau, Kate ^b   Bäckström, B Thomas ^b  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NITRIC OXIDE; PROTEIN P40; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DOWN REGULATION; ENCEPHALITIS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHISTOSOMA; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SPINAL CORD; SPLEEN CELL; T LYMPHOCYTE; TH2 CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; MACROPHAGES; MICE; MICE, INBRED C57BL; MYELIN-ASSOCIATED GLYCOPROTEIN; NEUTROPHILS; NITRIC OXIDE; SCHISTOSOMIASIS MANSONI; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042825468     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.9.4996-5004.2003     Document Type: Article

References (44)

1. Abdul-Majid, K. B., A. Stefferl, C. Bourquin, H. Lassmann, C. Linington, T. Olsson, S. Kleinau, and R. A. Harris. 2002. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scand. J. Immunol. 55:70-81.
2. Arap Siongok, T. K., A. A. Mahmoud, J. H. Ouma, K. S. Warren, A. S. Muller, A. K. Handa, and H. B. Houser. 1976. Morbidity in schistosomiasis mansoni in relation to intensity of infection: study of a community in Machakos, Kenya. Am. J. Trop. Med. Hyg. 25:273-284.
3. Araujo, M. I., A. A. Lopes, M. Medeiros, A. A. Cruz, L. Sousa-Atta, D. Sole, and E. M. Carvalho. 2000. Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int. Arch. Allergy Immunol. 123:145-148.
4. Becher, B., B. G. Durell, and R. J. Noelle. 2002. Experimental autoimmune encephalomyelitis and inflammation in the absence of IL-12. J. Clin. Investig. 110:493-497.
5. Brown, H. W., and F. A. Neva. 1975. Blood flukes of man, p. 239-252. In Basic clinical parasitology, 4th ed. Appleton-Century-Crofts, New York, N.Y.
6. Brunet, L. R., F. D. Finkelman, A. W. Cheever, M. A. Kopf, and E. J. Pearce. 1997. IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. J. Immunol. 159:777-785.
7. Butterworth, A. E., A. J. Curry, D. W. Dunne, A. J. Fulford, G. Kimani, H. C. Kariuki, R. Klumpp, D. Koech, G. Mbugua, J. H. Ouma, et al. 1994. Immunity and morbidity in human schistosomiasis mansoni. Trop. Geogr. Med. 46:197-208.
8. Chiaramonte, M. G., L. R. Schopf, T. Y. Neben, A. W. Cheever, D. D. Donaldson, and T. A. Wynn. 1999. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J. Immunol. 162:920-930.
9. Cooke, A., P. Tonks, F. M. Jones, H. O'Shea, P. Hutchings, A. J. Fulford, and D. W. Dunne. 1999. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 21:169-176.
10. Cua, D., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, S. Zurawski, M. Wiekowski, S. A. Lira, D. Gorman, R. A. Kastelein, and J. D. Sedgwick. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammmation of the brain. Nature 421:744-748.
11. Curry, A. J., K. J. Else, F. Jones, A. Bancroft, R. K. Grencis, and D. W. Dunne. 1995. Evidence that cytokine-mediated immune interactions induced by Schistosoma mansoni alter disease outcome in mice concurrently infected with Trichuris muris. J. Exp. Med. 181:769-774.
12. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3:944-950.
13. Gerber, J. S., and D. M. Mosser. 2001. Stimulatory and inhibitory signals originating from the macrophage Fcγ receptors. Microbes Infect. 3:131-139.
14. Green, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
15. Grzych, J. M., E. Pearce, A. Cheever, Z. A. Caulada, P. Caspar, S. Heiny, F. Lewis, and A. Sher. 1991. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J. Immunol. 146:1322-1327.
16. Hesse, M., M. Modolell, A. C. La Flamme, M. Schito, J. M. Fuentes, A. W. Cheever, E. J. Pearce, and T. A. Wynn. 2001. Differential regulation of NOS-2 and arginase-1 by type-1/type-2 cytokines in vivo. Granuloma pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167:6533-6544.
17. Hjelmstrom, P., A. E. Juedes, and N. H. Ruddle. 1998. Cytokines and antibodies in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis. Res. Immunol. 149:794-804; 847-848; 855-860.
18. Kahana, E. 2000. Epidemiologic studies of multiple sclerosis: a review. Biomed. Pharmacother. 54:100-102.
19. Kuchroo, V. K., R. A. Sobel, J. C. Laning, C. A. Martin, E. Greenfield, M. E. Dorf, and M. B. Lees. 1992. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein: fine specificity and T-cell receptor V beta usage. J. Immunol. 148:3776-3782.
20. Kurtzke, J. F. 2000. Multiple sclerosis in time and space: geographic clues to cause. J. Neurovirol. 6(Suppl. 2):S134-S140.
21. La Flamme, A. C., P. Scott, and E. J. Pearce. 2002. Schistosomiasis delays lesion resolution during Leishmania major infection by impairing parasite killing by macrophages. Parasite Immunol. 24:339-345.
22. Leonard, J. P., K. E. Waldburger, and S. J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381-386.
23. Lyons, J. A., M. J. Ramsbottom, and A. H. Cross. 2002. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur. J. Immunol. 32:1905-1913.
24. Lyons, J. A., M. San, M. P. Happ, and A. H. Cross. 1999. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29:3432-3439.
25. MacDonald, A. S., P. Loke, and J. E. Allen. 1999. Suppressive antigenpresenting cells in helminth infection. Pathobiology. 67:265-268.
26. Marshall, A. J., L. R. Brunet, Y. van Gessel, A. Alcaraz, S. K. Bliss, E. J. Pearce, and E. Y. Denkers. 1999. Toxoplasma gondii and Schistosoma mansoni synergize to promote hepatocyte dysfunction associated with high levels of plasma TNF-alpha and early death in C57BL/6 mice. J. Immunol. 163:2089-2097.
27. Martiney, J. A., A. J. Rajan, P. C. Charles, A. Cerami, P. C. Ulrich, S. Macphail, K. J. Tracey, and C. F. Brosnan. 1998. Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agent. J. Immunol. 160:5588-5595.
28. Miller, D. H., S. R. Hammond, J. G. McLeod, G. Purdie, and D. C. Skegg. 1990. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? J. Neurol. Neurosurg. Psychiatry 53:903-905.
29. Mills, C. D., K. Kincaid, J. M. Alt, M. J. Heilman, and A. M. Hill. 2000. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164:6166-6173.
30. Nicolson, K., S. Freland, C. Weir, B. Delahunt, R. A. Flavell, and B. T. Backstrom. 2002. Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2. Int. Immunol. 14:849-856.
31. Overbergh, L., D. Valckx, M. Waer, and C. Mathieu. 1999. Quantification of murine cytokine mRNAs using real-time quantitative reverse transcriptase PCR. Cytokine 11:305-312.
32. Palanivel, V., C. Posey, A. M. Horauf, W. Solbach, W. F. Piessens, and D. A. Harn. 1996. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. Exp. Parasitol. 84:168-177.
33. Pearce, E. J., A. Cheever, S. Leonard, M. Covalesky, R. Fernandez-Botran, G. Kohler, and M. Kopf. 1996. Schistosoma mansoni in IL-4-deficient mice. Int. Immunol. 8:435-444.
34. Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Shevach, and M. Rocken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961-1966.
35. Reed, S. G., C. E. Brownell, D. M. Russo, J. S. Silva, K. H. Grabstein, and P. J. Morrissey. 1994. IL-10 mediates susceptibility to Tryponosoma cruzi infection. J. Immunol. 153:3135-3140.
36. Schmittgen, T. D., and B. A. Zakrajsek. 2000. Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J. Biochem. Biophys. Methods 46:69-81.
37. Selmaj, K., C. S. Raine, B. Cannella, and C. F. Brosnan. 1991. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Investig. 87:949-954.
38. Sewell, D., Z. Qing, E. Reinke, D. Elliot, J. Weinstock, M. Sandor, and Z. Fabry. 2003. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int. Immunol. 15:59-69.
39. Shaw, M. K., J. B. Lorens, A. Dhawan, R. DalCanto, H. Y. Tse, A. B. Tran, C. Bonpane, S. L. Eswaran, S. Brocke, N. Sarvetnick L. Steinman, G. P. Nolan, and C. G. Fathman. 1997. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1711-1714.
40. Steinman, L. 1999. Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 24:511-514.
41. Sutterwala, F. A., G. J. Noel, R. Clynes, and D. M. Mosser. 1997. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 185:1977-1985.
42. Svensson, L., K. B. Abdul-Majid, J. Bauer, H. Lassmann, R. A. Harris, and R. Holmdahl. 2002. A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination. Eur. J. Immunol. 32:1939-1946.
43. Tran, E. H., K. Hoekstra, N. van Rooijen, C. D. Dijkstra, and T. Owens. 1998. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J. Immunol. 161:3767-3775.
44. Xia, D., A. Sanders, M. Shah, A. Bickerstaff, and C. Orosz. 2001. Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice. Transplantation 72:907-914.